Vimian Group AB VIMIAN

Morningstar Rating
SEK 42.70 +0.70 (1.67%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

VIMIAN is trading at a LOCK|d!&%<x premium.
Price
SEK 42.00
Fair Value
LOCK|.^v!SLY
Uncertainty
LOCK|mH<b
1-Star Price
LOCK|.^@^N>>
5-Star Price
LOCK|.g#%Wy>s
Economic Moat
LOCK|WZlR&
Capital Allocation
—

Trading Information

Previous Close Price
SEK 42.00
Day Range
SEK 41.80–42.90
52-Week Range
SEK 24.18–42.90
Bid/Ask
SEK 42.70 / SEK 42.75
Shares Outstanding
528.08M
Market Cap
SEK 22.55B
Volume/Avg
284,587 / 430,692

Key Statistics

Price/Earnings (Normalized)
34.61
Price/Sales
4.38
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

Vimian Group AB specializes in the areas of animal health, such as specialty pharma, diagnostics, medtech, and veterinary services. It offers proprietary diagnostics, prescription, and non-prescription treatments for preventive care and treatment of chronic conditions for companion animals, with a position within allergy, dermatology, otology, and specialized nutrition. Its geographical segments include Europe, North America, and the Rest of the world.
Sector
Healthcare
Industry
Diagnostics & Research
Stock Style Box
Small Growth
Total Number of Employees
1,300

Valuation

Metric
VIMIAN
Price/Earnings (Normalized)
34.61
Price/Book Value
2.62
Price/Sales
4.38
Price/Cash Flow
23.30
Price/Earnings
VIMIAN

Financial Strength

Metric
VIMIAN
Quick Ratio
1.65
Current Ratio
2.73
Interest Coverage
3.74
Quick Ratio
VIMIAN

Profitability

Metric
VIMIAN
Return on Assets (Normalized)
3.80%
Return on Equity (Normalized)
6.10%
Return on Invested Capital (Normalized)
5.94%
Return on Assets
VIMIAN

Diagnostics & Research Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Thermo Fisher Scientific Inc
TMO
LOCK|Q!@>>crLOCK|kc$254B
Danaher Corp
DHR
LOCK|!lm<$DYtLOCK|$g$159B
IDEXX Laboratories Inc
IDXX
LOCK|f%^czQYLOCK|fWx$54B
Agilent Technologies Inc
A
LOCK|D>?Nw%KLOCK|K&$49B
Waters Corp
WAT
LOCK|lPPx#>vLOCK|m>$44B
IQVIA Holdings Inc
IQV
LOCK|C^y>$@wLOCK|%<%X$42B
Mettler-Toledo International Inc
MTD
LOCK|!bN<!b<LOCK|&X#kP$34B
Illumina Inc
ILMN
LOCK|$v&B%Z!LOCK|&<t^$31B
Labcorp Holdings Inc
LH
LOCK|!q%%Qy^lLOCK|BR$L$$30B
Quest Diagnostics Inc
DGX
LOCK|r?Hpy?zLOCK|N^?zl$28B

Sponsor Center